Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyoshi Harashima

Showing results (101-110 of 496) with videos related to

Pageof 50
Sort By:
International Journal of Pharmaceutics|June 7, 2011
Dual imaging of mRNA and protein production: an investigation of the mechanism of heterogeneity in cationic lipid-mediated transgene expressionHidetaka Akita, Yuko Umetsu, Dai Kurihara, et al.
International Journal of Pharmaceutics|August 9, 2015
The intracellular pharmacodynamics of siRNA is responsible for the low gene silencing activity of siRNA-loaded nanoparticles in dendritic cellsTakashi Nakamura, Yuki Fujiwara, Shota Warashina, et al.
Advances in Biochemical Engineering/Biotechnology|April 4, 2009
A novel nonviral gene delivery system: multifunctional envelope-type nano deviceHiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Biological & Pharmaceutical Bulletin|December 4, 2003
Calpain 10 as a predictive gene for type 2 diabetes: evidence from a novel screening system using white blood cells of Otsuka Long-Evans Tokushima Fatty (OLETF) ratsYuichiro Sato, Masamichi Kuwajima, Hiroyuki Kamiya, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid]Hiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Expert Opinion on Drug Delivery|November 8, 2014
Advances in an active and passive targeting to tumor and adipose tissuesYu Sakurai, Kazuaki Kajimoto, Hiroto Hatakeyama, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 4, 2026
Mitochondria-targeted coenzyme Q<sub>10</sub> nanocarriers evaluated by particle size and lipid composition alleviate early acetaminophen-induced liver injuryMitsue Hibino, Yukari Muramatsu, Hideyoshi Harashima, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 9, 2013
Localization of exogenous DNA to mitochondria in skeletal muscle following hydrodynamic limb vein injectionYukari Yasuzaki, Yuma Yamada, Tsutomu Kanefuji, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2013
The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administrationTakashi Nakamura, Daiki Yamazaki, Jun Yamauchi, et al.
International Journal of Pharmaceutics|May 29, 2016
Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumorsGolam Kibria, Hiroto Hatakeyama, Yusuke Sato, et al.
Pageof 50

Showing results (101-110 of 496) with videos related to

Sort By:
Pageof 50
International Journal of Pharmaceutics|June 7, 2011
Dual imaging of mRNA and protein production: an investigation of the mechanism of heterogeneity in cationic lipid-mediated transgene expressionHidetaka Akita, Yuko Umetsu, Dai Kurihara, et al.
International Journal of Pharmaceutics|August 9, 2015
The intracellular pharmacodynamics of siRNA is responsible for the low gene silencing activity of siRNA-loaded nanoparticles in dendritic cellsTakashi Nakamura, Yuki Fujiwara, Shota Warashina, et al.
Advances in Biochemical Engineering/Biotechnology|April 4, 2009
A novel nonviral gene delivery system: multifunctional envelope-type nano deviceHiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Biological & Pharmaceutical Bulletin|December 4, 2003
Calpain 10 as a predictive gene for type 2 diabetes: evidence from a novel screening system using white blood cells of Otsuka Long-Evans Tokushima Fatty (OLETF) ratsYuichiro Sato, Masamichi Kuwajima, Hiroyuki Kamiya, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid]Hiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Expert Opinion on Drug Delivery|November 8, 2014
Advances in an active and passive targeting to tumor and adipose tissuesYu Sakurai, Kazuaki Kajimoto, Hiroto Hatakeyama, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 4, 2026
Mitochondria-targeted coenzyme Q<sub>10</sub> nanocarriers evaluated by particle size and lipid composition alleviate early acetaminophen-induced liver injuryMitsue Hibino, Yukari Muramatsu, Hideyoshi Harashima, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 9, 2013
Localization of exogenous DNA to mitochondria in skeletal muscle following hydrodynamic limb vein injectionYukari Yasuzaki, Yuma Yamada, Tsutomu Kanefuji, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2013
The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administrationTakashi Nakamura, Daiki Yamazaki, Jun Yamauchi, et al.
International Journal of Pharmaceutics|May 29, 2016
Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumorsGolam Kibria, Hiroto Hatakeyama, Yusuke Sato, et al.
Pageof 50